The Aptima HIV-1 Quant assay will significantly cut lab times.
HIV
Latest News
Advertisement
CME Content
Advertisement
Combination treatment methods to cure HIV may have harmful side effects.
Certain protease inhibitors linked to cognitive issues.
HIV resistance may necessitate more costly therapies for third-line treatment.
Combination treatment with rilpivirine and dolutegravir demonstrated non-inferiority to other regimens.
Two-drug combination with rilpivirine and dolutegravir demonstrated non-inferiority to other HIV regimens.
A toxin in bee venom may put an end to HIV in the future.
Top articles of the year on Specialty Pharmacy Times.
Experts agree that integrated antiretroviral therapy (ART) for HIV-positive partners and time-limited pre-exposure prophylaxis (PrEP) for negative partners almost eliminates HIV transmission.
Combination drugs may cause adverse events in individuals coinfected with HIV and HCV.
Top articles of 2016 on Specialty Pharmacy Times.
Over the years, a number of landmark clinical studies in virology have been published, shaping how we treat the disease today.
Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today
Top HIV articles of the year on Specialty Pharmacy Times.
HIV hiding in the brain can cause damage to the patient.
Patients share their personal stories with Specialty Pharmacy Times.
Syringe services programs seek to halt the spread of HIV among injection drug users.
Syringe services programs (SSPs) aim to reduce the spread of HIV among people who inject drugs (PWID), as use of shared needles puts them at high risk of contracting or transmitting the infection.
An antiretroviral vaginal ring is being investigated to quell the spread of HIV.
The state’s health department recommends that patients be screened for HIV, and hepatitis B and C viruses.
HIV infection continues to rise in across European countries.
Top news of the day from across the health care landscape.
Lack of adherence to HIV medications can create resistance since the virus mutates quickly.
Pennsylvania health department recommends that patients be screened for HIV, and hepatitis B and C viruses.
Integrase inhibitors can reduce the HIV viral load to decrease transmission of the disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief
2
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
3
The Weekly Dose: AHA Says Coffee Is Safe for Most, Wildfire Smoke Risks for Respiratory Patients, and New Options for Sleep Apnea, ROS1-Positive Lung Cancer
4
Online GLP-1 Sellers Often Skip Clinician Oversight, Secret Shopper Study Finds
5